Navigation Links
Upsher-Smith Announces Commercial Availability Of Morphine Sulfate ER Capsules
Date:8/29/2013

MAPLE GROVE, Minn., Aug. 29, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., today announced its Morphine Sulfate Extended-Release Capsules, CII will be commercially available on September 4, 2013.

(Logo:  http://photos.prnewswire.com/prnh/20130520/NY17281LOGO )

Historically, there have been a limited number of morphine sulfate generics available.  Upsher-Smith used its extensive formulation experience to overcome the challenges presented.

Upsher-Smith's family of Morphine Sulfate Extended-Release Capsules, CII includes seven dosage strengths: 10 mg, 20 mg, 30 mg, 50 mg, 60 mg, 80 mg, and 100 mg.  This will be the first generic entrant for the 10-mg extended-release capsule dosage strength.1 Upsher-Smith's generic drug segment is dedicated to providing high-quality pharmaceutical products that are affordable and accessible to patients.

About Upsher-Smith
Upsher-Smith is an independent specialty pharmaceutical company dedicated to its mission of Advancing Pharmacotherapy to Improve Life™. Upsher-Smith currently leverages its core strength in formulation development to drive both branded and generic therapeutic solutions to address patients' needs ranging in scope from women's health to cardiology. The Company has a particular focus on developing therapies for people living with challenging central nervous system conditions like epilepsy, and has an emerging neurology pipeline with three products in clinical development.  For more information, visit www.upsher-smith.com.

Please see Full Prescribing Information, including Boxed Warning, at http://www.upsher-smith.com/wp-content/uploads/MorphineSulfate_MI.pdf.

References
1. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. http://www.accessdata.fda.gov/scripts/cder/ob/docs/tempai.cfm.  Accessed May 9, 2013.


'/>"/>
SOURCE Upsher-Smith Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Upsher-Smith Teams Up With Epilepsy Foundation Of Minnesota For 2013 Stroll For Epilepsy
2. Upsher-Smith Announces Patient Enrollment In Open-label Safety Study Of USL261 (Intranasal Midazolam) For Rescue Treatment Of Seizure Clusters In Epilepsy
3. Upsher-Smith Is Honored With Prestigious Industry Award For Leadership And Innovation
4. Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures
5. Upsher-Smith Introduces Newly Redesigned Corporate Website
6. Upsher-Smith Presents Data Supporting Favorable Tolerability And Consistent Pharmacokinetic Profile Of Once-Daily USL255 (Extended-Release Topiramate)
7. Emerging Data From Upsher-Smiths CNS Portfolio Highlighted At 2013 American Academy Of Neurology Meeting
8. Doug Zitnak of Upsher-Smith Laboratories Named Small Brand Manufacturer Representative of the Year By Cardinal Health
9. Tina Fehr, Senior Product Manager For AmLactin, Upsher-Smith Laboratories Named PM360 Trailblazer Winner For Womens Health Brand Manager
10. Upsher-Smith Teams Up With Epilepsy Foundation of Minnesota for 2012 Stroll for Epilepsy
11. Upsher-Smith Is Honored with Prestigious Industry Award for Excellence and Innovation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... 22, 2017 Kineta, Inc., a biotechnology ... immune modulating therapies, today announced that KCP-400 (RgIA4), ... receptor (nAChR), demonstrates robust chronic pain relief and ... study also establishes the a9a10 nAChR as a ... pain. The findings were reported online in the ...
(Date:2/22/2017)... and HAMBURG, Germany , February 22, 2017 ... precision oncology headquartered in Hamburg, Germany and ... research institution, announced today a collaboration to support the first Indian ... research. ... Indivumed signed an agreement with an initial three-year term. The collaboration ...
(Date:2/21/2017)... NEW YORK , Feb. 21, 2017 ... equipment with specialized versions are used to monitor physiological ... or as remote patient monitors. Remote patient monitoring is ... of the patient monitoring equipment in the market. Hence, ... integrated with smartphones and applications, which can send test ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... February 22, 2017 , ... ... newest advanced absorption cannabidiol (CBD) serum, “NANOCALM 300” Microemulsified Hemp Extract. This ... instant absorption from the mouth into the bloodstream. Far outpacing the ...
(Date:2/22/2017)... ... February 22, 2017 , ... Becker’s Spine Review, the leading ... Michigan neurosurgeon Jay Jagannathan, M.D., as a “Spine Surgeon to Know.” http://www.beckersspine.com/spine-leaders/item/35348- ... in Michigan performing minimally invasive back surgery that often results in less post-operative ...
(Date:2/22/2017)... ... February 22, 2017 , ... The SeniorCare Investor will host an important ... February 23, 2017, at 1:00 PM ET. A recording of the webinar will also ... Webinar Series. , If you want to find out what really happened in the ...
(Date:2/22/2017)... ... , ... BrightStar Care Charleston , a home care and medical staffing ... (MUSC) Center on Aging’s Senior Expo on Thursday, March 23, 2017, at the ... resource in our community. We are thrilled to participate in this event because we ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... pipeline and the number of African American/Black students who want to become physicians. ... to pursue their careers as physicians in the Oakland/San Francisco Northern California, Bay ...
Breaking Medicine News(10 mins):